Sonnet BioTherapeutics (SONN) Institutional Ownership $2.90 -0.02 (-0.68%) (As of 11/21/2024 ET) Add Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Sonnet BioTherapeutics (NASDAQ:SONN)CurrentInstitutional OwnershipPercentage9.45%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$255KNumber ofInstitutional Sellers(last 12 months)0 Get SONN Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SONN Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Sonnet BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC272,000$255K0.0%N/A8.740% 7/27/2023Virtu Financial LLC86,624$42K0.0%N/A0.315% 5/19/2023 Anson Funds Management LP1,760,000$634K0.1%N/A6.405% 11/7/2022Virtu Financial LLC26,914$40K0.0%N/A0.622% 8/2/2022 Advisory Services Network LLC130,525$37K0.0%+158.3%0.215% 5/10/2022 Campion Asset Management90,612$34K0.0%N/A0.150% 8/16/2021 State Street Corp62,688$99K0.0%N/A0.253% 8/13/2021 Vanguard Group Inc.701,634$1.11M0.0%+416.0%2.834% 5/19/2021Virtu Financial LLC65,106$146K0.0%N/A0.371% 5/18/2021 Citadel Advisors LLC113,264$255K0.0%N/A0.534% 5/18/2021 Jane Street Group LLC17,304$39K0.0%N/A0.099% 5/17/2021 Price T Rowe Associates Inc. MD45,100$101K0.0%N/A0.257% 5/13/2021 Bank of New York Mellon Corp20,399$46K0.0%N/A0.116% 5/7/2021BlackRock Inc.255,761$575K0.0%+3.7%1.457% 3/26/2021 Susquehanna International Group LLP15,434$34K0.0%N/A0.088% 2/9/2021 Advisory Services Network LLC24,581$55K0.0%+32.3%0.143% 2/5/2021BlackRock Inc.246,555$550K0.0%+2.5%1.435% 11/19/2020 Schonfeld Strategic Advisors LLC12,200$31K0.0%N/A0.071% 11/19/2020 IHT Wealth Management LLC10,000$26K0.0%N/A0.058% 11/17/2020 Schonfeld Strategic Advisors LLC12,200$31K0.0%N/A0.089% (Data available from 1/1/2016 forward) SONN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SONN shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonnet BioTherapeutics shares: Anson Funds Management LP ($634K), and Armistice Capital LLC ($255K), Virtu Financial LLC ($42K).Learn more on SONN's institutional investors. What percentage of Sonnet BioTherapeutics stock is owned by institutional investors? 9.45% of Sonnet BioTherapeutics stock is owned by institutional investors. Learn more on SONN's institutional investor holdings. Which institutional investors have been buying Sonnet BioTherapeutics stock? The following institutional investors have purchased Sonnet BioTherapeutics stock in the last 24 months: Anson Funds Management LP ($1.76M), Armistice Capital LLC ($272K), and Virtu Financial LLC ($86.62K). How much institutional buying is happening at Sonnet BioTherapeutics? Institutional investors have bought a total of 2,118,624 shares in the last 24 months. This purchase volume represents approximately $15.13M in transactions. This page (NASDAQ:SONN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
